EMEA-002486-PIP04-21-M01 - paediatric investigation plan
Catequentinib
PIPHuman
Key facts
- Active Substance
- Catequentinib
- Therapeutic area
- Neoplasms benign, malignant and unspecified (incl cysts and polyps)
- Decision number
- P/0110/2024
- PIP number
- EMEA-002486-PIP04-21-M01
- Pharmaceutical form(s)
- Age-appropriate oral dosage formulation
- Capsule, hard
- Condition(s) / indication(s)
- Treatment of Ewing sarcoma
- Treatment of soft tissue sarcomas
- Route(s) of administration
- Oral use
- Contact for public enquiries
Advenchen Laboratories, LLC
info@advenchen.com
+1 8055301550
- Decision type
- PM: decision on the application for modification of an agreed PIP
- Decision date